BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19560852)

  • 1. Association of level of kidney function and platelet aggregation in acute myocardial infarction.
    Karlsson F; Modica A; Mooe T
    Am J Kidney Dis; 2009 Aug; 54(2):262-9. PubMed ID: 19560852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
    Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A
    Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired renal function in acute myocardial infarction.
    Lekston A; Kurek A; Tynior B
    Cardiol J; 2009; 16(5):400-6. PubMed ID: 19753517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Spontaneous" platelet aggregation in whole blood in diabetic and non diabetic survivors of acute myocardial infarction.
    Gray RP; Hendra TJ; Patterson DL; Yudkin JS
    Thromb Haemost; 1993 Dec; 70(6):932-6. PubMed ID: 8165614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART).
    Szummer K; Lundman P; Jacobson SH; Schön S; Lindbäck J; Stenestrand U; Wallentin L; Jernberg T;
    Circulation; 2009 Sep; 120(10):851-8. PubMed ID: 19704097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of platelet activation in diabetic and non-diabetic subjects during the course of an acute myocardial infarction.
    Karlsson F; Modica A; Mooe T
    Thromb Res; 2007; 121(2):269-73. PubMed ID: 17543372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction.
    Miyamoto S; Sakamoto T; Soejima H; Shimomura H; Kajiwara I; Kojima S; Hokamaki J; Sugiyama S; Yoshimura M; Ozaki Y; Nakamura H; Yodoi J; Ogawa H
    Am Heart J; 2003 Sep; 146(3):465-71. PubMed ID: 12947364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet hyperreactivity and prognosis in survivors of myocardial infarction.
    Trip MD; Cats VM; van Capelle FJ; Vreeken J
    N Engl J Med; 1990 May; 322(22):1549-54. PubMed ID: 2336086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between age and platelet activation in patients with stable and unstable angina.
    Gilstad JR; Gurbel PA; Andersen RE
    Arch Gerontol Geriatr; 2009; 48(2):155-9. PubMed ID: 18282622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morning blood pressure surge, morning platelet aggregation, and silent cerebral infarction in older Japanese hypertensive patients.
    Kario K; Yano Y; Matsuo T; Hoshide S; Asada Y; Shimada K
    J Hypertens; 2011 Dec; 29(12):2433-9. PubMed ID: 22025234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of renal dysfunction and glucometabolic status on one month mortality after acute myocardial infarction.
    Schiele F; Seronde MF; Descotes-Genon V; Blonde MC; Legalery P; Meneveau N; Ecarnot F; Penfornis A; Ducloux D; Bassand JP
    Acute Card Care; 2007; 9(1):34-42. PubMed ID: 17453537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function following acute cerebral ischemia.
    Smout J; Dyker A; Cleanthis M; Ford G; Kesteven P; Stansby G
    Angiology; 2009; 60(3):362-9. PubMed ID: 19398427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
    Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
    Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of acute exertion and physical training on platelet function of the coronary patient].
    Broustet JP; Boisseau M; Bouloumie J; Emeriau JP; Bricaud H
    Arch Mal Coeur Vaiss; 1976 Mar; 69(3):305-13. PubMed ID: 828016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of platelets behaviour in controls and acute myocardial infarction patients.
    Deshpande NJ; Rao KR
    Indian J Physiol Pharmacol; 1998 Apr; 42(2):307-10. PubMed ID: 10225064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of do-not-resuscitate orders in patients with kidney disease hospitalized with acute myocardial infarction.
    Chen JL; Sosnov J; Lessard D; Yarzebski J; Gore J; Goldberg R
    Am J Kidney Dis; 2007 Jan; 49(1):83-90. PubMed ID: 17185148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alimentary lipemia enhances procoagulatory effects of inflammation in patients with a history of acute myocardial infarction complicated by ventricular fibrillation.
    Kälsch T; Elmas E; Nguyen XD; Leweling H; Klüter H; Borggrefe M; Dempfle CE
    Int J Cardiol; 2008 Jan; 123(2):131-7. PubMed ID: 17374548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.